Medicare AdvantageCoverageMedium impact
Erectile Dysfunction and Peyronie's Disease Treatments - Medicare Advantage (Revised)
Humana·Urology·Medicare Advantage
Effective date
Feb 2, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has issued a revised policy for erectile dysfunction and Peyronie's disease treatments, effective February 2, 2026. This policy outlines coverage determinations for various ED and PD treatments including penile implants, vacuum erection devices, surgical procedures, and experimental therapies like PRP and stem cell treatments.
Action Required
Before February 2, 2026: Review current billing practices for erectile dysfunction and Peyronie's disease treatments to ensure compliance with Humana Medicare Advantage coverage requirements. Verify that vacuum erection device claims follow CMS LCD L34824 guidelines. Update prior authorization workflows for experimental treatments like PRP therapy, shockwave therapy, and stem cell therapy which may not be covered.